Related Experiment Video
Updated: Jul 6, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein
Yuka Nomura1, Yusuke Abe, Yoshiya Ishida
1Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical College, Midorigaoka E2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan.
Insights
New vaccine strategies are needed for nontypeable Haemophilus influenzae (NTHi) infections, especially in children with recurrent ear infections. Researchers identified P6 protein peptides that can enhance immune responses for a broadly applicable NTHi vaccine.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Nontypeable Haemophilus influenzae (NTHi) causes recurrent acute otitis media.
- The P6 outer membrane protein is a vaccine candidate against NTHi.
- Otitis-prone children exhibit an impaired immune response to P6.
Purpose of the Study:
- To develop an innovative vaccination approach for NTHi.
- To identify broadly applicable peptide vaccine candidates from the P6 protein.
- To augment the immune response in individuals with impaired responses to P6.
Main Methods:
- Identification of promiscuous T cell epitope peptides on P6 (p41-55, p71-85).
- Selection of additional peptides (p30-44, p45-59) using a computer algorithm.
- Establishment of peptide-specific T cell lines responding to P6.
Main Results:
- Previously identified HLA-DR9-restricted T cell epitopes and analogs on P6.
- Identified promiscuous T cell epitope peptides (p41-55, p71-85) for broader applicability.
- Established peptide-specific T cell lines demonstrating responsiveness to P6.
Conclusions:
- The identified P6 peptides are candidates for a widely applicable peptide vaccine formulation.
- This approach aims to overcome the impaired immune response to P6 in certain populations.
- Further development could lead to effective NTHi vaccines for the general population.
Introduction:
P6 outer membrane protein is one of the candidates for a vaccine formulation against nontypeable Haemophilus influenzae (NTHi) infection. As otitis-prone children who have recurrent episodes of acute otitis media because of NTHi show an impaired immune response to P6, an innovative approach to vaccination is required to augment their immune response.
Results And Discussion:
We previously identified human HLA-DR9-restricted T cell epitope peptide and highly immunogenic analog peptides on P6 for peptide vaccine candidates. To develop a vaccine formulation effective in the general population, we identified promiscuous T cell epitope peptides (p41-55, p71-85) on P6. In addition to stimulating with potentially promiscuous peptides (p30-44, p45-59) selected using a computer algorithm, we established peptide-specific T cell lines which respond to P6.
Conclusion:
Our present results indicate that these peptides would be candidates for a widely applicable peptide vaccine formulation.
Related Concept Videos
Fimbriae, Pili, and Axial Filaments
Leaky Scanning
Gram-negative Bacterial Protein Secretion Systems
Formation of Lipopolysaccharides
Peptidoglycan Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis

